Production (Stage)
Cellectis S.A.
CMVLF
$1.25
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 47.63M | 41.51M | 29.07M | 13.03M | 5.14M |
| Total Other Revenue | 7.12M | 7.71M | 6.97M | 6.61M | 6.99M |
| Total Revenue | 54.75M | 49.22M | 36.04M | 19.64M | 12.13M |
| Cost of Revenue | -- | -- | 737.00K | 737.00K | 737.00K |
| Gross Profit | 54.75M | 49.22M | 35.31M | 18.90M | 11.40M |
| SG&A Expenses | 18.68M | 19.09M | 18.82M | 16.88M | 16.95M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -1.24M | -849.00K | -192.00K | -5.00K | 153.00K |
| Total Operating Expenses | 107.59M | 108.77M | 114.00M | 107.49M | 106.40M |
| Operating Income | -52.84M | -59.56M | -77.95M | -87.85M | -94.26M |
| Income Before Tax | -60.27M | -36.76M | -84.99M | -79.25M | -83.25M |
| Income Tax Expenses | 262.00K | 0.00 | -508.00K | -343.00K | 108.00K |
| Earnings from Continuing Operations | -60.53 | -36.76 | -84.48 | -78.90 | -83.36 |
| Earnings from Discontinued Operations | -- | -- | 0.00 | 0.00 | 13.08M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | 0.00 | 0.00 | 4.93M |
| Net Income | -60.53M | -36.76M | -84.48M | -78.90M | -65.34M |
| EBIT | -52.84M | -59.56M | -77.95M | -87.85M | -94.26M |
| EBITDA | -41.05M | -48.25M | -67.22M | -77.39M | -84.09M |
| EPS Basic | -0.63 | -0.37 | -1.07 | -1.16 | -1.09 |
| Normalized Basic EPS | -0.38 | -0.22 | -0.56 | -0.69 | -0.75 |
| EPS Diluted | -0.64 | -0.60 | -1.30 | -1.39 | -1.32 |
| Normalized Diluted EPS | -0.38 | -0.23 | -0.57 | -0.70 | -0.77 |
| Average Basic Shares Outstanding | 390.20M | 361.85M | 326.99M | 282.48M | 248.21M |
| Average Diluted Shares Outstanding | 390.20M | 393.13M | 358.27M | 313.76M | 279.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |